PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Copyright policy )PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Two soldiers continued weekly prophylaxis with 300 mg chloroquine base on their return to Australia from Papua New Guinea but were not protected against Plasmodium vivax malaria. Both had symptoms and parasitaemia although plasma concentrations of chloroquine were considerably higher than those regarded as adequate for suppression of vivax malaria. Parasitaemia did not clear after one of the patients was treated with 600 mg chloroquine base. The results suggest the emergence of strains of P vivax with a reduced susceptibility to chloroquine.
- University of Sydney Australia
Male, Blood Specimen Collection, Drug Resistance, Chloroquine, Drug Administration Schedule, Malaria, Antimalarials, Drug Combinations, Papua New Guinea, Pyrimethamine, Acute Disease, Animals, Drug Evaluation, Humans, Plasmodium vivax, Dapsone
Male, Blood Specimen Collection, Drug Resistance, Chloroquine, Drug Administration Schedule, Malaria, Antimalarials, Drug Combinations, Papua New Guinea, Pyrimethamine, Acute Disease, Animals, Drug Evaluation, Humans, Plasmodium vivax, Dapsone
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).456 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 0.1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!